Tom Lawry

National Director for AI, Health & Life Sciences, Microsoft

Tom Lawry serves as National Director of AI for Health & Life Sciences at Microsoft and previously served as Director of Worldwide Health. Tom works with providers, payors and life science organizations in planning & implementing innovative analytical solutions that improve the quality and efficiency of health services delivered around the globe.

Tom focuses on strategies for digital transformation applied to performance optimization including Artificial Intelligence (AI), Machine Learning (ML) and Cognitive Services. He previously served as Director of Organizational Performance for Microsoft’s health incubator (Health Solutions Group).
Prior to Microsoft Tom served as a Senior Director at GE Healthcare with global responsibilities for revenue cycle management analytics and operational performance solutions.

Lawry was founder and CEO of Verus, a healthcare software company named as one of the Top 100 Fastest Growing Washington Companies for three consecutive years and to the Deloitte Fast 500 Technologies list.

For twelve years Lawry served in various executive management roles in hospitals and integrated delivery networks. He has published numerous articles on topics relating to use technology to innovate healthcare. His new book from HIMSS & CRC Press is: Artificial Intelligence in Healthcare: A Leader’s Guide to Winning in the New Age of Intelligent Health Systems.

Representative Keynote Conference Presentations

“AI in Health – The Future is not What I Used to be,” Arab Health CEO forum, Dubai, UAE, Feb. 2020.
“AI, Digital, and the Creative Destruction of Careers in Healthcare,” Sandra Rotman Centre for Health Sector Strategy, Toronto, Canada, May 2019
“Changing the Face of Healthcare with Artificial Intelligence,” The Intelligent Health Association’s AI in Health Conference, Las Vegas, NV, March 2018
“Empowering Healthcare with Systems of Intelligence,” HIMSS, Las Vegas, NV, March 2018
“Digital Transformation in Health – What Can Health Learn from the Private Sector?” The Nobel Forum, Stockholm, Sweden, March 2017
AI is Healthcare’s Next Big Thing,” European Health Innovation Summit, Brussels, Belgium, January 2017
“Health Policy in an Era of Big Data & Digital Transformation,” Commonwealth Fund International Symposium on Health Policy, Washington, D.C., November 2016
“The Transformative Power of Big Data in Health”, Asan International Medical Symposium, Seoul, South Korea, June 2016
“What will the Future of Technology Innovation Bring to Health?”, High Reliability Health Conference, Johns Hopkins University, Baltimore MD, February 2017
“Empowering Health – the Innovator’s Perspective”, European Health Summit, Brussels, Belgium, Jan. 2017

Speaker Sessions

13. The Ethics of AI in Health: Creating Value that Benefits Everyone

(Machine Learning/AI — Course Level: Intermediate)

AI is no longer about the future. It’s about the present and what clinical and business leaders are doing today to leverage this next big shift in healthcare’s computing platform. As AI solutions become more pervasive, a host of ethical issues are coming forward. How we address them will determine whether AI will be a force for good for some—or all—health consumers.

In this session, Tom Lawry, author of the book, “Artificial Intelligence in Healthcare: A Leader’s Guide to Winning in the New Age of Intelligent Health Systems,” will define key ethical issues for use of AI in health, during a pandemic, and provide recommendations for creating a framework to guide its use in keeping with an organization’s mission and values.

Thank You for a Great Virtual Summit! See You Next Year for HAS 21.

Replay HAS 20 Virtual

Unsupported Browser

Unfortunately your web browser is out of date. For improved security, speed and the best experience please consider using the latest version of on the following browsers: Google Chrome, Firefox, Edge, Safari, or Opera.

This site uses cookies

We take pride in providing you with relevant, useful content. May we use cookies to track what you read? We take your privacy very seriously. Please see our privacy policy for details and any questions.